3002.12.00.30/Hepatitis B Immune Globulin (HBIG)/Japan

Hepatitis B Immune Globulin (HBIG) from Japan

HBIG is a human immune serum providing high-titer anti-HBs antibodies for post-exposure prophylaxis against hepatitis B virus. Classified in HTS 3002.12.0030 as human immune blood sera from HBV-vaccinated or recovered donors. It is essential for preventing mother-to-child transmission and needle-stick exposures.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Declare HBsAg titer (>50,000 IU/L) on invoice; FDA requires lot release protocol

• Use insulated shipping with temperature logs (-20°C to -80°C) to prevent denaturation